Bristol Myers Squibb Operating Margin 2006-2021 | BMY

Current and historical operating margin for Bristol Myers Squibb (BMY) over the last 10 years. The current operating profit margin for Bristol Myers Squibb as of September 30, 2021 is 35.44%.
Bristol Myers Squibb Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2021-09-30 $45.47B $-4.21B -9.26%
2021-06-30 $44.38B $-4.11B -9.26%
2021-03-31 $42.81B $-4.04B -9.43%
2020-12-31 $42.52B $-6.87B -16.16%
2020-09-30 $39.40B $3.45B 8.76%
2020-06-30 $34.86B $2.54B 7.29%
2020-03-31 $31.01B $2.69B 8.68%
2019-12-31 $26.15B $4.98B 19.03%
2019-09-30 $24.17B $6.61B 27.34%
2019-06-30 $23.86B $7.43B 31.13%
2019-03-31 $23.29B $6.17B 26.49%
2018-12-31 $22.56B $5.97B 26.45%
2018-09-30 $22.04B $5.16B 23.42%
2018-06-30 $21.60B $4.18B 19.34%
2018-03-31 $21.04B $4.96B 23.55%
2017-12-31 $20.78B $5.13B 24.70%
2017-09-30 $20.57B $5.52B 26.83%
2017-06-30 $20.24B $5.90B 29.13%
2017-03-31 $19.97B $6.22B 31.13%
2016-12-31 $19.43B $5.92B 30.45%
2016-09-30 $18.47B $4.42B 23.92%
2016-06-30 $17.62B $3.85B 21.84%
2016-03-31 $16.91B $2.28B 13.51%
2015-12-31 $16.56B $2.08B 12.54%
2015-09-30 $16.53B $2.43B 14.68%
2015-06-30 $16.38B $2.45B 14.94%
2015-03-31 $16.11B $2.84B 17.65%
2014-12-31 $15.88B $2.38B 14.99%
2014-09-30 $16.06B $3.31B 20.61%
2014-06-30 $16.21B $3.12B 19.25%
2014-03-31 $16.37B $3.20B 19.57%
2013-12-31 $16.39B $2.89B 17.64%
2013-09-30 $16.14B $2.54B 15.71%
2013-06-30 $15.81B $2.29B 14.48%
2013-03-31 $16.20B $2.82B 17.39%
2012-12-31 $17.62B $4.17B 23.66%
2012-09-30 $18.88B $5.37B 28.46%
2012-06-30 $20.49B $6.57B 32.06%
2012-03-31 $21.48B $7.28B 33.88%
2011-12-31 $21.24B $6.98B 32.86%
2011-09-30 $20.90B $6.86B 32.81%
2011-06-30 $20.35B $6.67B 32.77%
2011-03-31 $19.69B $6.43B 32.68%
2010-12-31 $19.48B $6.07B 31.16%
2010-09-30 $19.41B $5.73B 29.53%
2010-06-30 $19.40B $5.63B 29.01%
2010-03-31 $19.29B $5.51B 28.58%
2009-12-31 $18.81B $5.32B 28.29%
2009-09-30 $16.14B $4.38B 27.11%
2009-06-30 $16.61B $3.95B 23.76%
2009-03-31 $17.15B $3.63B 21.17%
2008-12-31 $17.72B $3.51B 19.83%
2008-09-30 $17.58B $2.91B 16.57%
2008-06-30 $16.92B $2.74B 16.16%
2008-03-31 $16.19B $2.48B 15.34%
2007-12-31 $15.62B $2.19B 14.04%
2007-09-30 $15.90B $1.91B 12.02%
2007-06-30 $15.45B $1.53B 9.92%
2007-03-31 $15.85B $1.66B 10.44%
2006-12-31 $16.21B $1.77B 10.93%
2006-09-30 $18.12B $3.10B 17.12%
2006-06-30 $18.73B $3.55B 18.96%
2006-03-31 $18.75B $3.60B 19.18%
2005-12-31 $18.61B $3.70B 19.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.747B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88